We are live on ! Find out more
NCM

Nantahala Capital Management Portfolio holdings

AUM $2.72B
1-Year Est. Return 121.58%
This Fund
S&P 500
This Quarter Est. Return
-11.58%
1 Year Est. Return
+121.58%
3 Year Est. Return
+308.64%
5 Year Est. Return
+308.9%
10 Year Est. Return
+2,888.73%
AUM
$2.26B
AUM Growth
-$582M
Cap. Flow
-$263M
Cap. Flow %
-11.62%
Top 10 Hldgs %
52.07%
Holding
149
New
14
Increased
25
Reduced
74
Closed
27

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$66.4M
2
LNW
Light & Wonder
LNW
+$63.6M
3
PTON icon
Peloton Interactive
PTON
+$14M
4
FTVI
FinTech Acquisition Corp. VI Class A Common Stock
FTVI
+$9.79M
5
AMYT
Amryt Pharma plc American Depositary Shares
AMYT
+$9.67M

Top Sells

Rank Stock Value
1
GDEN
Golden Entertainment
GDEN
+$19.5M
2
SC
SANTANDER CONSUMER USA HOLDINGS INC
SC
+$16.6M
3
STR
Sitio Royalties
STR
+$11.6M
4
AKBA icon
Akebia Therapeutics
AKBA
+$10.5M
5
FTVIU
FinTech Acquisition Corp. VI Units
FTVIU
+$10M

Sector Composition

Rank Sector Weight
1 Healthcare 26.38%
2 Consumer Discretionary 13.81%
3 Financials 5.18%
4 Industrials 5.14%
5 Technology 4.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HLF icon
51
CALL
Herbalife
HLF
$1.23B
$8.13M 0.36%
267,700
-10,300
-4% -$403K
HERA
52
DELISTED
FTAC Hera Acquisition Corp. Class A Ordinary Shares
HERA
$7.83M 0.35%
800,001
-131,190
-14% -$1.28M
SRL icon
53
Scully Royalty
SRL
$89.7M
$7.58M 0.34%
772,437
-34,652
-4% -$308K
SYRE icon
54
Spyre Therapeutics
SYRE
$9.06B
$7.36M 0.33%
128,024
+15,482
+14% +$1.3M
MAX icon
55
MediaAlpha
MAX
$801M
$7.24M 0.32%
437,494
+67,090
+18% +$939K
SSKN
56
DELISTED
Strata Skin Sciences
SSKN
$6.73M 0.3%
457,581
– –
AURA icon
57
Aura Biosciences
AURA
$834M
$6.64M 0.29%
301,990
+202,844
+205% +$3.86M
VMD icon
58
Viemed Healthcare
VMD
$354M
$6.44M 0.29%
1,293,812
-129,726
-9% -$602K
AKU
59
DELISTED
Akumin Inc
AKU
$6.19M 0.27%
5,578,992
-741,748
-12% -$922K
CRIS icon
60
Curis
CRIS
$4.56M
$5.9M 0.26%
6,196
+217
+4% +$277K
CBAY
61
DELISTED
Cymabay Therapeutics
CBAY
$5.89M 0.26%
1,893,997
-106,145
-5% -$334K
RILY icon
62
BRC Group Holdings
RILY
$292M
$5.49M 0.24%
78,508
-14,869
-16% -$1.01M
ONTF
63
DELISTED
ON24
ONTF
$5.05M 0.22%
+384,088
New +$5.77M
AVTX icon
64
Avalo Therapeutics
AVTX
$1.05B
$4.8M 0.21%
2,378
-103
-4% -$259K
PWP icon
65
Perella Weinberg Partners
PWP
$1.32B
$4.75M 0.21%
502,676
+224,536
+81% +$2.39M
CDTX
66
DELISTED
Cidara Therapeutics
CDTX
$4.13M 0.18%
247,744
-15,779
-6% -$268K
VRM icon
67
CALL
Vroom Inc
VRM
$51.5M
$3.99M 0.18%
18,750
– –
NPCE icon
68
Neuropace
NPCE
$512M
$3.98M 0.18%
485,303
+179,397
+59% +$1.55M
NAUT icon
69
Nautilus Biotechnolgy
NAUT
$113M
$3.88M 0.17%
893,561
-136,311
-13% -$560K
KURA icon
70
CALL
Kura Oncology
KURA
$882M
$3.87M 0.17%
240,900
-9,100
-4% -$131K
W icon
71
Wayfair
W
$14.1B
$3.84M 0.17%
+34,688
New +$4.88M
HLGN
72
DELISTED
Heliogen, Inc.
HLGN
$3.38M 0.15%
18,389
-3,754
-17% -$685K
MACK
73
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$3.27M 0.14%
516,817
-53,154
-9% -$299K
ARYD
74
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$3.19M 0.14%
325,848
-73,400
-18% -$722K
SPRY icon
75
ARS Pharmaceuticals
SPRY
$592M
$3.15M 0.14%
913,597
-92,865
-9% -$404K
1 2
3
4 5

Similar funds

TAM
Timucuan Asset Management Jacksonville, Florida $2.72B AUM 4.95% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
PA
Profund Advisors Bethesda, Maryland $2.72B AUM 47.27% 1-Year Est. Return
BCM
Bowie Capital Management Richardson, Texas $2.71B AUM 5.42% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return
LP
Longaeva Partners Chicago, Illinois $2.7B AUM 37.16% 1-Year Est. Return

Nantahala Capital Management's Q1 2022 Portfolio in Review

As of Q1 2022, Nantahala Capital Management held 149 positions worth $2.26B, down 20% from $2.84B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Nantahala Capital Management withdrew a net $263M in Q1 2022, closing 27 positions and reducing 74 holdings. Its most notable exit was SANTANDER CONSUMER USA HOLDINGS INC, an estimated $16.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 27% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Nantahala Capital Management opened a new position in FinTech Acquisition Corp. VI Class A Common Stock worth $9.82M.

  • Nantahala Capital Management's largest Q1 2022 buy was FinTech Acquisition Corp. VI Class A Common Stock: 999,992 shares worth $9.82M.
  • Nantahala Capital Management added most to iShares Russell 2000 ETF in Q1 2022, an estimated $66.4M increase.
  • Nantahala Capital Management's biggest Q1 2022 reduction was Golden Entertainment, cutting an estimated $19.5M.
  • Nantahala Capital Management fully exited SANTANDER CONSUMER USA HOLDINGS INC in Q1 2022, selling an estimated $16.6M.
  • Nantahala Capital Management's ten largest holdings make up 52% of its $2.26B portfolio in Q1 2022.
  • Nantahala Capital Management opened 14 new positions and closed 27 in Q1 2022.
  • Nantahala Capital Management's portfolio value fell 20% quarter-over-quarter to $2.26B.

Based on Nantahala Capital Management's 13F filing for Q1 2022, filed 13 May 2022.